YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Key Points Interested in Fulgent Genetics, Inc.? Here are five stocks we like better. Second-quarter revenue rose to $85.4 million, up 20% sequentially, with Bako Diagnostics and StrataDx contributing $16.9 million. However, billing-system…
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Healthcare stocks have remained in focus as investors look for companies that can deliver strong operational growth w…
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential vio…
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential vio…
Fulgent Genetics, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Performance was impacted by a planned transition of testing in-house by the company's largest customer, resulting in a $6 million seq…
Fulgent Genetics, Inc. (FLGT) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring i…
iRhythm Holdings, Inc. (IRTC) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.95 per share a year ago. These figures are adjusted for non-recurring ite…
NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential v…
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT) investors concerning the Company’s and/or members of…
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT) investors concerning the Company’s and/or me…
NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential v…
NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) for potential v…
[manhattan office building] franckreporter/iStock via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices nex…
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT). Such investors are advised to contact Danielle Peyton at newac…
SAN DIEGO, March 02, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Fulgent Genetics, Inc. (NASDAQ: FLGT). The investigation focuses on Fulgent’s executive officers and whether inv…
Earnings Call Insights: Fulgent Genetics (FLGT) Q4 2025 MANAGEMENT VIEW * Ming Hsieh, Chairman & CEO, highlighted strategic progress in both laboratory services and therapeutic development, noting, "We have implemented the best-in-class te…
Fulgent Genetics (FLGT) reported Friday Q4 sales below market expectations, and its forecasts for no PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Cheniere Energy, Inc. LNG is set to release fourth-quarter 2025 results on Feb. 26. The Zacks Consensus Estimate for earnings is pegged at $3.83 per share on revenues of $5.17 billion. Let us delve into the factors that are likely to have…
[earnings] MCCAIG The last week of February brings another packed stretch of earnings, with a mix of megacap technology leaders, consumer bellwethers, energy producers, financial firms, and high-growth disruptors set to report. The lineup…
Doximity (DOCS) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This…
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Ero Copper Corp. ERO: This copper mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days. Ero Copper…
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire StrataDx — two well-known pathology testing companies — in a combined transaction valued at $55.5 million. Expecte…
* Fulgent Genetics press release [https://seekingalpha.com/pr/20298686-fulgent-reports-third-quarter-2025-financial-results] (FLGT [https://seekingalpha.com/symbol/FLGT]): Q3 Non-GAAP EPS of $0.14 beats by $0.36. * Revenue of $84.07M (+17.…
Evolent Health (EVH) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.…
Schrodinger, Inc. SDGR shares soared 13.8% in the last trading session to close at $21.98. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 0.7% loss over the pa…
Investing.com - UBS upgraded Fulgent Genetics (NASDAQ:FLGT) from Neutral to Buy and raised its price target to $30.00 from $20.00 as analyst coverage of the company changes hands. The company maintains a strong financial position with more…
Key Points The company posted an unexpected profit in its latest reported quarter. That was accompanied by a double-digit improvement in revenue. 10 stocks we like better than Fulgent Genetics › Friday's stock market was generally a gloomy…
Earnings Call Insights: Fulgent Genetics (FLGT) Q2 2025 MANAGEMENT VIEW * Ming Hsieh, CEO, stated that "We are pleased with our second quarter results. We have shown both sequential and year-over-year growth in laboratory services." He hig…
Fulgent Genetics reported its Q2 2025 earnings, showcasing a revenue of $81.8 million, surpassing the forecast of $76.21 million. The company reported an EPS of $0.07, missing the forecasted EPS of $-0.18. This result represents a surprise…
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. [premarket] GAINERS TICKER CHANGE COMMENT MWYN [https://www.chartmill.c…
Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for n…
* Fulgent Genetics press release [https://seekingalpha.com/pr/20186155-fulgent-reports-second-quarter-2025-financial-results] (NASDAQ:FLGT [https://seekingalpha.com/symbol/FLGT]): Q2 Non-GAAP EPS of $0.07 beats by $0.25. * Revenue of $81.8…
September S&P 500 E-Mini futures (ESU25) are down -0.93%, andSeptember Nasdaq 100 E-Mini futures (NQU25) are down -1.03% this morning as U.S. President Donald Trump’s sweeping import tariffs fueled concerns about the outlook for economic g…
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are down -0.93%, and September Nasdaq 100 E-Mini futures (NQU25 [https://www.barchart.com/futures/quotes/NQU25/overview]) are down -1.03% this morning…
Major earnings expected before the bell on Friday include: * Exxon Mobil Corporation (XOM [https://seekingalpha.com/symbol/XOM]) * Chevron Corporation (CVX [https://seekingalpha.com/symbol/CVX]) * Enbridge (ENB [https://seekingalpha.com/sy…
[COVID-19 - laboratory team working on coronavirus vaccine. Protective workwear] janiecbros/E+ via Getty Images * Fulgent Genetics (NASDAQ:FLGT [https://seekingalpha.com/symbol/FLGT]) has received European Union’s CE certification for its…